France to probe GSK, Sanofi vaccination campaign

French authorities are investigating GlaxoSmithKline and Sanofi Pasteur over an anti-hepatitis B vaccination campaign in the 1990s. At issue is whether the companies fully disclosed the shot's potential side effects.

The probe also includes accusations of manslaughter against Sanofi Pasteur MSD, a joint venture of Sanofi Aventis and Merck. The allegations stem from the death of a young woman from multiple sclerosis; the woman had been vaccinated. A Sanofi official called the charges "unjustified," saying that 11 studies have shown no link between the hepatitis B vaccine and MS.

The vaccination campaign in question ran from 1994 to 1998, but then was suspended because of concerns about possible side effects. Thirty plaintiffs have filed civil claims, including the families of five who died after being vaccinated.

- read the story at CNN Money
- read more background at Pharmalot

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.